JeuveauTM (prabotulinumtoxinA-xvfs) by Evolus is now FDA approved for the temporary improvement of moderate to severe glabellar lines in adults.
Jeuveau also known as #NEWTOX, is another purified form of botulinum toxin that has been shown to deliver temporary improvement in moderate to severe frown lines by blocking the signal from the nerve to the muscles, ultimately resulting in a reduction of muscle activity, temporarily preventing contraction of the muscles that cause frown lines and reducing the appearance of movement lines. Jeuveau is another excellent, non-surgical option that reduces the effects of aging and helps regain a more youthful appearance.
So, what's the difference between Jeuveau and Botox?
Like Botox, Dysport, and Xeomin, Jeuveau is used to temporarily improve the appearance of frown lines between the eyebrows — technically called the glabellar lines, but often referred to as the "11s." (Off-label, wrinkle relaxers are also used to treat other areas, like crow's feet around the eyes and smile lines.) Like Botox, Jeuveau has a molecular weight of 900 kDa, but they're produced in different facilities and are derived from different strains of the same toxin. (Botox, or onabotulinumtoxinA, is made by Allergan in Westport, Ireland; Jeuveau, or prabotulinumtoxinA, comes out of Seoul, South Korea.) The risks and potential side effects listed by the companies are also identical.